$134.50
-0.52 (-0.39%)
Novo Nordisk A/S (ADR) (NYSE:NVO)
CAPS Rating:
Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.
RSS Headlines
Fool UK